Book your 68Ga-PSMA PET-CT Scan at Molecular Diagnostics and Therapy, an NABL & NABH-accredited diagnostic centre that offers advanced Nuclear Medicine, Radiology, and Pathology services. This specialized PET-CT scan employs Gallium-68 PSMA (68Ga-PSMA) to detect lesions that express Prostate-Specific Membrane Antigen (PSMA) and is special because it is used in cancer diagnosis, especially when looking at prostate cancer. PET shows how they are working. Our specialized nuclear medicine physicians employ cutting-edge PET-CT technology under proper radiation safety protocols for accurate scanning.
About 68Ga-PSMA PET-CT
The 68Ga-PSMA PET-CT Scan is a specialized nuclear medicine examination mainly used for the evaluation of prostate cancer. The 68Ga–PSMA tracer binds to cell types that express PSMA and is detected on the PET scan. It offers information on both function and anatomy, helping physicians to assess disease extent.
What is a 68Ga-PSMA PET-CT?
During a 68Ga-PSMA PET-CT scan, a small dose of the radioactive tracer, 68Ga-PSMA, is injected. The patient lies in the PET-CT machine for the full-body scan. The PET component creates a high-energy light beam onto the prostate to look for increased PSMA activity, and the CT component is used to get anatomical information. The two images, when combined, aid doctors in determining the location and extent of prostate cancer.
Common Reasons for 68Ga-PSMA PET-CT
Detection of prostate cancer
Staging of prostate cancer
Evaluation of suspected recurrence
Detection of metastatic disease
Assessment of rising PSA levels
Localization of PSMA-positive lesions
Treatment planning
Follow-up after prostate cancer treatment
Conditions Evaluated
Prostate Cancer
Helps detect and localize PSMA-expressing prostate cancer lesions.
Recurrent Prostate Cancer
Supports evaluation of suspected recurrence, particularly when PSA levels rise after treatment.
Metastatic Prostate Cancer
Helps identify the spread of prostate cancer to lymph nodes, bones, and other sites.
Lymph Node Involvement
Can help detect PSMA-positive lymph node metastases for accurate staging.
Bone Metastases
Helps identify PSMA-expressing prostate cancer deposits in the bones.
Who Should Consider This Scan?
Your doctor may recommend a 68Ga-PSMA PET-CT Scan if you:
Have suspected or confirmed prostate cancer
Need staging before treatment
Have rising PSA after treatment
Have suspected recurrent disease
Need evaluation for metastatic prostate cancer
Require assessment of PSMA-positive lesions
Benefits of 68Ga-PSMA PET-CT
Provides whole-body functional imaging
Helps detect PSMA-expressing lesions
Combines PET functional information with CT anatomy
Helps assess disease spread
Supports staging and treatment planning
Useful for evaluating suspected recurrence
Why Choose Molecular Diagnostics and Therapy?
Experienced Nuclear Medicine Specialists
Advanced PET-CT Imaging Technology
NABL & NABH Accredited Diagnostic Centre
Accurate and reliable reporting
Appropriate radiation safety protocols
Affordable and transparent pricing
Comprehensive Nuclear Medicine, Radiology, and Pathology services under one roof
Book Your 68Ga-PSMA PET-CT
Book your 68Ga-PSMA PET-CT scan at Molecular Diagnostics and Therapy. The functional and anatomical imaging capabilities of our nuclear medicine team facilitate evaluation of prostate cancer, recurrent disease, lymph node involvement, bone metastases, and other PSMA-expressing lesions.
Test information: Fasting is not required.
Reporting: Within 24 hours*
Fasting may be required depending on the scan protocol. Follow the fasting instructions provided by the Nuclear Medicine team.
Stay adequately hydrated before and after the scan unless otherwise advised by your doctor.
Inform the Nuclear Medicine team about your current medications, ongoing treatments, and relevant medical conditions.
If you are pregnant, may be pregnant, or are breastfeeding, inform the Nuclear Medicine team before the scan.
Carry previous PSA reports, PET-CT scans, CT/MRI reports, biopsy reports, treatment records, or other relevant medical documents, if available.
Do not stop or change any prescribed medication unless specifically advised by your doctor.
Follow all instructions regarding food, fluids, medications, and activity provided before the examination.
Follow the radiation-safety and post-scan instructions provided by the Nuclear Medicine team.
जांच की प्रक्रिया के अनुसार खाली पेट रहना आवश्यक हो सकता है। न्यूक्लियर मेडिसिन टीम द्वारा बताए गए समय तक भोजन न करने के निर्देशों का पालन करें।
डॉक्टर द्वारा अन्यथा न बताए जाने पर जांच से पहले और बाद में पर्याप्त मात्रा में पानी पिएं।
अपनी वर्तमान दवाइयों, चल रहे उपचार और संबंधित स्वास्थ्य समस्याओं के बारे में न्यूक्लियर मेडिसिन टीम को जानकारी दें।
यदि आप गर्भवती हैं, गर्भवती होने की संभावना है या स्तनपान करा रही हैं, तो जांच से पहले टीम को अवश्य बताएं।
उपलब्ध होने पर पिछली पीएसए जांच रिपोर्ट, पीईटी-सीटी, सीटी, एमआरआई, बायोप्सी रिपोर्ट, उपचार संबंधी दस्तावेज या अन्य चिकित्सकीय अभिलेख साथ लेकर आएं।
डॉक्टर की सलाह के बिना कोई भी निर्धारित दवा बंद न करें और उसकी खुराक में बदलाव न करें।
जांच से पहले भोजन, पानी, दवाइयों और अन्य गतिविधियों से संबंधित दिए गए सभी निर्देशों का पालन करें।
जांच के बाद न्यूक्लियर मेडिसिन टीम द्वारा दिए गए विकिरण सुरक्षा और अन्य सावधानियों संबंधी निर्देशों का पालन करें।
The patient is registered, and relevant clinical details, PSA levels, previous imaging, biopsy findings, and treatment history are reviewed.
A small amount of 68Ga-PSMA radiotracer is administered intravenously under appropriate supervision.
An uptake period is provided to allow the tracer to circulate and accumulate in areas expressing PSMA.
The patient is positioned comfortably on the PET-CT scanner table.
PET imaging is performed to identify areas of increased PSMA tracer uptake throughout the scanned body region.
CT imaging provides detailed anatomical information and helps accurately localize areas of tracer uptake.
PET and CT images are combined to provide functional and anatomical information for clinical evaluation.
The images are assessed for PSMA-expressing lesions and possible involvement of lymph nodes, bones, or other sites.
Relevant clinical history and previous reports are considered during interpretation.
Appropriate radiation-safety measures and imaging quality-control protocols are followed throughout the examination.
The scan is generally well tolerated, although the total procedure time may vary according to the clinical protocol.
The images are reviewed by experienced Nuclear Medicine Specialists before the final report is prepared.
* For details, please see service-related policies
Disclaimer: The information provided on this page is for educational and informational purposes only.
It is not intended to replace professional medical advice, diagnosis, or treatment.
Always consult a qualified healthcare professional for advice regarding your individual health condition or treatment.